Clinic Investment Opportunities in Garut

The company is currently in the pre-revenue stage and is setting up a private primary healthcare clinic in Talegong, Garut under KBLI 86105 with a micro-business scale. - The clinic aims to serve a market of approximately 45,000 residents, including around 3,000 BPJS participants, with an initial target of approximately 20 patients per day. - Revenue will be generated through multiple streams, including BPJS capitation payments, general patient consultations, pharmacy drug sales, and basic laboratory services, creating stable and recurring cash flow. - Once operational, the business projects monthly revenue of IDR 65–69 million, totaling approximately IDR 780–828 million annually. - The clinic expects an EBITDA margin of 25–30% and estimates reaching break-even within 2–3 years. - The business follows an integrated one-stop healthcare service model, with minimal direct competition in the area, creating a strong market gap and significant growth potential. - The company has already secured its NIB license, supporting its readiness to launch operations.

The company is currently in the pre-revenue stage and is setting up a private primary healthcare clinic in Talegong, Garut under KBLI 86105 with a micro-business scale. - The clinic aims to serve a market of approximately 45,000 residents, including around 3,000 BPJS participants, with an initial target of approximately 20 patients per day. - Revenue will be generated through multiple streams, including BPJS capitation payments, general patient consultations, pharmacy drug sales, and basic laboratory services, creating stable and recurring cash flow. - Once operational, the business projects monthly revenue of IDR 65–69 million, totaling approximately IDR 780–828 million annually. - The clinic expects an EBITDA margin of 25–30% and estimates reaching break-even within 2–3 years. - The business follows an integrated one-stop healthcare service model, with minimal direct competition in the area, creating a strong market gap and significant growth potential. - The company has already secured its NIB license, supporting its readiness to launch operations.